Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $8,350 | 9 | 58.1% |
| Education | $3,000 | 1 | 20.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,500 | 2 | 10.4% |
| Food and Beverage | $867.19 | 11 | 6.0% |
| Unspecified | $352.00 | 1 | 2.4% |
| Travel and Lodging | $308.63 | 4 | 2.1% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Intuitive Surgical, Inc. | $4,671 | 5 | $0 (2022) |
| Janssen Global Services, LLC | $3,752 | 2 | $0 (2021) |
| Seagen Inc. | $2,813 | 6 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $1,192 | 1 | $0 (2021) |
| Astellas Pharma Global Development | $625.00 | 1 | $0 (2021) |
| UroGen Pharma, Inc. | $523.11 | 2 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $445.52 | 5 | $0 (2017) |
| Photocure Inc | $239.37 | 3 | $0 (2017) |
| Ferring Pharmaceuticals Inc. | $87.17 | 2 | $0 (2019) |
| 180 Medical, Inc. | $29.06 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $625.00 | 1 | Seagen Inc. ($625.00) |
| 2022 | $5,921 | 7 | Intuitive Surgical, Inc. ($4,500) |
| 2021 | $6,550 | 8 | Janssen Global Services, LLC ($3,752) |
| 2020 | $352.00 | 1 | UROGEN PHARMA, INC. ($352.00) |
| 2019 | $244.34 | 3 | Intuitive Surgical, Inc. ($157.17) |
| 2017 | $684.89 | 8 | SANOFI-AVENTIS U.S. LLC ($445.52) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/05/2023 | Seagen Inc. | — | Consulting Fee | Cash or cash equivalent | $625.00 | General |
| 11/18/2022 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $750.00 | General |
| Category: SURGERY | ||||||
| 11/16/2022 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $750.00 | General |
| Category: SURGERY | ||||||
| 08/17/2022 | Seagen Inc. | — | Consulting Fee | Cash or cash equivalent | $625.00 | General |
| 08/17/2022 | Seagen Inc. | — | Consulting Fee | Cash or cash equivalent | $312.50 | General |
| 08/17/2022 | Seagen Inc. | — | Consulting Fee | Cash or cash equivalent | $312.50 | General |
| 06/08/2022 | Intuitive Surgical, Inc. | DA VINCI SP (Device) | Education | In-kind items and services | $3,000.00 | General |
| Category: SURGERY | ||||||
| 04/05/2022 | UroGen Pharma, Inc. | — | Food and Beverage | In-kind items and services | $171.11 | General |
| 12/02/2021 | Janssen Global Services, LLC | DARZALEX (Drug) | Food and Beverage | In-kind items and services | $32.42 | General |
| Category: Oncology | ||||||
| 11/23/2021 | Seagen Inc. | — | Consulting Fee | Cash or cash equivalent | $625.00 | General |
| 11/23/2021 | Astellas Pharma Global Development | Padcev (Drug) | Consulting Fee | Cash or cash equivalent | $625.00 | General |
| Category: Oncology | ||||||
| 11/23/2021 | Seagen Inc. | — | Consulting Fee | Cash or cash equivalent | $312.50 | General |
| 11/23/2021 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: SURGERY | ||||||
| 11/15/2021 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Consulting Fee | Cash or cash equivalent | $1,192.00 | General |
| Category: Oncology | ||||||
| 07/01/2021 | Janssen Global Services, LLC | — | Consulting Fee | Cash or cash equivalent | $3,720.00 | General |
| 06/19/2021 | 180 Medical, Inc. | — | Food and Beverage | Cash or cash equivalent | $29.06 | General |
| 12/31/2020 | UROGEN PHARMA, INC. | JELMYTO (Drug) | — | Cash or cash equivalent | $352.00 | Research |
| Study: OLYMPUS FINAL MANUSCRIPT • Category: UROTHELIAL CANCER | ||||||
| 06/07/2019 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $157.17 | General |
| Category: SURGERY | ||||||
| 05/04/2019 | Ferring Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $35.96 | General |
| 02/15/2019 | Ferring Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $51.21 | General |
| 10/07/2017 | SANOFI-AVENTIS U.S. LLC | NO PRODUCT DISCUSSED (Drug) | Travel and Lodging | Cash or cash equivalent | $144.05 | General |
| 10/07/2017 | SANOFI-AVENTIS U.S. LLC | NO PRODUCT DISCUSSED (Drug) | Food and Beverage | In-kind items and services | $136.89 | General |
| 10/07/2017 | SANOFI-AVENTIS U.S. LLC | NO PRODUCT DISCUSSED (Drug) | Travel and Lodging | Cash or cash equivalent | $22.02 | General |
| 10/06/2017 | SANOFI-AVENTIS U.S. LLC | NO PRODUCT DISCUSSED (Drug) | Travel and Lodging | In-kind items and services | $71.28 | General |
| 10/05/2017 | SANOFI-AVENTIS U.S. LLC | NO PRODUCT DISCUSSED (Drug) | Travel and Lodging | In-kind items and services | $71.28 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| OLYMPUS FINAL MANUSCRIPT | UROGEN PHARMA, INC. | $352.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 345 | 427 | $116,940 | $32,073 |
| 2022 | 9 | 346 | 432 | $105,789 | $30,879 |
| 2021 | 10 | 367 | 454 | $154,741 | $46,453 |
| 2020 | 7 | 260 | 323 | $73,233 | $21,344 |
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 138 | 183 | $31,656 | $9,367 | 29.6% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 53 | 85 | $21,331 | $5,193 | 24.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 30 | 30 | $15,626 | $4,534 | 29.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 35 | 35 | $13,277 | $3,764 | 28.4% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Facility | 2023 | 24 | 24 | $11,509 | $3,067 | 26.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 34 | 34 | $9,210 | $2,683 | 29.1% |
| 52234 | Destruction and/or removal of growth of bladder and urethra using an endoscope, 0.5-2.0 cm | Facility | 2023 | 11 | 12 | $9,375 | $2,277 | 24.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2023 | 20 | 24 | $4,956 | $1,187 | 24.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 129 | 175 | $24,905 | $8,875 | 35.6% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2022 | 51 | 82 | $21,350 | $5,230 | 24.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 43 | 43 | $15,358 | $4,538 | 29.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 45 | 50 | $10,865 | $3,680 | 33.9% |
| 52234 | Destruction and/or removal of growth of bladder and urethra using an endoscope, 0.5-2.0 cm | Facility | 2022 | 13 | 14 | $10,973 | $2,652 | 24.2% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Facility | 2022 | 20 | 20 | $9,735 | $2,189 | 22.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 11 | 11 | $5,143 | $1,739 | 33.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2022 | 21 | 24 | $4,858 | $1,298 | 26.7% |
| 76998 | Ultrasonic guidance during surgery | Facility | 2022 | 13 | 13 | $2,601 | $677.80 | 26.1% |
| 50545 | Removal of kidney and lymph nodes using an endoscope | Facility | 2021 | 11 | 11 | $52,760 | $13,143 | 24.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 114 | 143 | $19,906 | $7,798 | 39.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 65 | 81 | $17,342 | $6,299 | 36.3% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Facility | 2021 | 51 | 89 | $22,606 | $5,526 | 24.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 37 | 37 | $13,002 | $4,230 | 32.5% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 22 | 22 | $10,096 | $3,520 | 34.9% |
| 52310 | Removal of foreign body, stone, or stent from bladder canal (urethra) or bladder using an endoscope | Facility | 2021 | 17 | 17 | $8,074 | $2,219 | 27.5% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2021 | 24 | 28 | $4,682 | $1,525 | 32.6% |
About Dr. John Gore, M.D
Dr. John Gore, M.D is a Urology healthcare provider based in Seattle, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/03/2007. The National Provider Identifier (NPI) number assigned to this provider is 1265553374.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Gore, M.D has received a total of $14,377 in payments from pharmaceutical and medical device companies, with $625.00 received in 2023. These payments were reported across 28 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($8,350).
As a Medicare-enrolled provider, Gore has provided services to 1,318 Medicare beneficiaries, totaling 1,636 services with total Medicare billing of $130,749. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Practice Information
- Specialty Urology
- Other Specialties Urology
- Location Seattle, WA
- Active Since 04/03/2007
- Last Updated 08/12/2009
- Taxonomy Code 208800000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1265553374
Products in Payments
- DA VINCI SP (Device) $3,000
- Da Vinci Surgical System (Device) $1,671
- OPDIVO (Biological) $1,192
- Padcev (Drug) $625.00
- NO PRODUCT DISCUSSED (Drug) $445.52
- JELMYTO (Drug) $352.00
- Cysview (Drug) $239.37
- DARZALEX (Drug) $32.42
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Seattle
Dr. James Porter, M.d, M.D
Urology — Payments: $764,015
Cristopher Garlitz, M.d, M.D
Urology — Payments: $303,210
Dr. Thomas Walsh, M.d, M.D
Urology — Payments: $279,672
Marah Hehemann, M.d, M.D
Urology — Payments: $264,034
Una Lee, M.d, M.D
Urology — Payments: $131,923
Alvaro Lucioni, M.d, M.D
Urology — Payments: $57,879